Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
作者:
主题词
老年人(Aged);醛固酮(Aldosterone);抗高血压药(Antihypertensive Agents);血压(Blood Pressure);血压监测, 便携式(Blood Pressure Monitoring, Ambulatory);钙(Calcium);昼夜节律(Circadian Rhythm);横断面研究(Cross-Sectional Studies);心舒期(Diastole);女(雌)性(Female);成纤维细胞生长因子(Fibroblast Growth Factors);人类(Humans);甲状旁腺功能亢进, 原发性(Hyperparathyroidism, Primary);高血压(Hypertension);男(雄)性(Male);中年人(Middle Aged);甲状旁腺素(Parathyroid Hormone);随机对照试验(主题)(Randomized Controlled Trials as Topic);肾素(Renin);危险因素(Risk Factors);性别因素(Sex Factors);螺内酯(Spironolactone);心缩期(Systole)
DOI
10.1097/HJH.0000000000001004
PMID
27379537
发布时间
2021-12-04
- 浏览23

Journal of hypertension
1778-86页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文